SecBot SecBot
144 ·Filed Jun 15, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 6/10
Horizonweeks Processed5mo ago SEC0001950047-26-006156
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sustained CEO selling pattern is a strong bearish signal that warrants caution. Traders should monitor for any negative pre-announcement or clinical data readout that may have prompted the insider to reduce exposure. If the selling continues at this pace, it could pressure the stock further despite bullish analyst consensus.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$57.61
T+0 close · Jun 15, 2026 · via day close
Latest settled
−4.25%
T+60 · $55.16
Vs SPY
−5.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 16 $57.61entry
  2. T+1 · 5mo ago −1.46%α −0.21% · $56.77
  3. T+5 · 5mo ago +3.16%α +5.39% · $59.43
  4. T+20 · 4mo ago +8.51%α +8.31% · $62.51
  5. T+60 · 2mo ago −4.25%α −5.25% · $55.16
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Dennis Mulroy filed a Form 144 notice of intent to sell 20,000 shares of ANAB common stock, valued at approximately $1.15 million, through Morgan Stanley. This filing is part of a sustained selling pattern: Mulroy has sold shares on nearly every trading day from May 15 through June 15, 2026, totaling over 296,000 shares and roughly $16.7 million in proceeds. The persistent insider selling at a $1.6B market-cap biotech with strong analyst consensus (94% bullish) is a notable bearish signal, suggesting management may be taking profits ahead of potential catalysts or de-risking personal exposure.

Key Facts

  • CEO Dennis Mulroy filed Form 144 to sell 20,000 shares (~$1.15M) on June 15, 2026.
  • Mulroy has sold shares on 18 of the last 22 trading days (May 15–June 15, 2026), totaling ~296,000 shares and ~$16.7M in proceeds.
  • The proposed sale is via a cash exercise of stock options, with the shares acquired from the issuer.
  • ANAB has a $1.6B market cap and 94% analyst bullish consensus (6 Strong Buy, 10 Buy, 1 Hold).
  • Top institutional holders include BlackRock ($93M), Morgan Stanley ($55M), and State Street ($55M).

Financial Impact

CEO selling ~$1.15M in a single notice, part of a sustained ~$16.7M selling wave over 22 trading days; represents a material reduction in insider ownership.

insider ownershipshare count

Risk Factors

  • CEO selling may signal undisclosed negative developments or a lack of confidence in near-term prospects.
  • Continued insider selling could erode investor sentiment and offset positive analyst ratings.
  • The selling may be for personal financial planning, but the volume and consistency are unusual for a routine diversification strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006156
Document: 0001950047-26-006156-index.html0001950047-26-006156
Document: 0001950047-26-006156.txt0001950047-26-006156

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026